Craig Scoville, MD
Rheumatology · Idaho Falls, IDNPI 1194818997
Payments from drug & device makers
Across 1,490 payments — averaging $505.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$199K
- Astrazeneca UK Limited$147K
- UCB SA$101K
- Pfizer$90K
- Novartis$80K
- AbbVie$54K
- plus $82K from 30 others
Across 9 payments — averaging $173.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 134 | $199,232 |
| Astrazeneca UK Limited | 10 | $146,712 |
| UCB SA | 23 | $101,051 |
| Pfizer | 112 | $89,794 |
| Novartis | 88 | $80,085 |
| AbbVie | 161 | $54,397 |
| Genentech, Inc. | 14 | $43,414 |
| Amgen(2 entities) | 517 | $13,654 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $8,151 |
| Regeneron | 14 | $6,227 |
| Astrazeneca AB | 1 | $2,700 |
| UCB, Inc. | 81 | $1,445 |
| Lilly USA, LLC | 62 | $1,030 |
| AstraZeneca(2 entities) | 36 | $807 |
| Mallinckrodt Hospital Products Inc. | 41 | $804 |
| E.r. Squibb & Sons, L.L.C. | 52 | $771 |
| Johnson & Johnson | 30 | $758 |
| Genentech USA, Inc. | 16 | $390 |
| Bristol Myers Squibb | 34 | $273 |
| Regeneron Healthcare Solutions, Inc. | 8 | $207 |
| Fresenius Kabi USA, LLC | 8 | $143 |
| Sobi, Inc | 4 | $128 |
| ANI Pharmaceuticals, Inc. | 5 | $115 |
| Organon | 5 | $96 |
| Janssen Scientific Affairs, LLC | 1 | $88 |
| Radius Health, Inc. | 5 | $86 |
| Sanofi | 5 | $83 |
| Boehringer Ingelheim | 3 | $61 |
| Sandoz | 3 | $59 |
| Boston Scientific | 3 | $54 |
| Mallinckrodt Enterprises LLC | 3 | $53 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $51 |
| Ultragenyx Pharmaceutical Inc. | 2 | $38 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $36 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
How this compares
$753,032 in reported general payments places this provider in the 95th percentile of 28 rheumatology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Idaho Falls
- William KnibbeBoise$925K
- James LovelessBoise$393K
- Dustin DinningCoeur D Alene$311K
- Craig WiesenhutterCoeur D Alene$79K
- Christopher GibsonAshton$39K
- Achini DingmanMeridian$37K
- Peggy Ann RuppBoise$11K
- Sean McMillanTwin Falls$4K
- Francis NardellaMeridian$3K
- Linda SakaiCoeur D Alene$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.